Related Experiment Videos
[Hyperbaric oxygen inhibits neutrophil infiltration and reduces postischemic brain injury in rats]
D N Atochin1, D Fisher, S R Thom
1M. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Acad. Sci., Russia, 194223, St. Petersburg, pr. M. Toreza, 44.
Abstract:
Reversible occlusion of the middle cerebral artery (MCA) was used to test hypothesis that hyperbaric oxygen inhibits the neutrophile infiltration into the ischemic brain thus reducing the brain injury. Treatment with hyperbaric oxygen prior to ischemia or during MCA occlusion significantly reduced neutrophile infiltration, motor disorders, and cerebral infarction volume.
Insights
Hyperbaric oxygen therapy can reduce brain damage after middle cerebral artery occlusion. This treatment significantly lowers neutrophil infiltration, motor deficits, and infarct volume in ischemic brain tissue.
Area of Science:
- Neuroscience
- Ischemic Stroke Research
- Hyperbaric Medicine
Context:
- Middle cerebral artery occlusion (MCAO) is a common model for ischemic stroke.
- Neutrophil infiltration plays a critical role in secondary brain injury following ischemia.
- Hyperbaric oxygen (HBO) is a therapeutic approach involving exposure to elevated oxygen levels.
Purpose:
- To investigate the neuroprotective effects of hyperbaric oxygen in a rodent model of ischemic stroke.
- To determine if hyperbaric oxygen inhibits neutrophil infiltration into the ischemic brain.
- To assess the impact of hyperbaric oxygen on functional recovery and brain tissue damage.
Summary:
- Reversible middle cerebral artery occlusion was employed to induce focal cerebral ischemia.
- Hyperbaric oxygen treatment, administered before or during ischemia, significantly reduced neutrophil infiltration.
- This inhibition of neutrophil infiltration correlated with decreased motor disorders and smaller cerebral infarction volumes.
Impact:
- Findings suggest hyperbaric oxygen is a promising therapeutic strategy for mitigating ischemic brain injury.
- HBO may offer a novel approach to reduce inflammation and neuronal damage in stroke patients.
- This research provides a basis for further clinical trials evaluating HBO in stroke management.